Alma Hybrid
CO2 Fractional/Ablative · CO2 10600nm + 1570nm fiber hybrid
Technology: CO2 Fractional Laser
Classification & configurations
Category group: Resurfacing & pigment (ablative, fractional, picosecond, vascular)
At a glance
- New price
- $120k–$160kSource not documented
- Used asking price
- $70k–$100kSource not documented
- FDA status
- Supplies & recurring costs
- See supply and replacement costs below.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers. Used asking prices are not completed-sale values.
Read FDA-cleared indicationsExact wording from 2 FDA records
K203441 (Alma Lasers, Ltd., 2021)
The Alma Hybrid Laser System, Delivery Devices, Applicators and Accessories are intended for use in surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including: aesthetic surgery (dermatology and plastic surgery). HyLight-CO2: The Alma Hybrid CO2 non-fractional applicator, with wavelength of 10600 nm is cleared for use for the particular indications as follows: Dermatology & Plastic Surgery — The ablation, vaporization, excision, incision, and coagulation of soft tissue in dermatology and plastic surgery in the performance of: • laser skin resurfacing • laser derm-abrasion • laser burn debridement. Laser skin resurfacing (ablation and/or vaporization) of soft tissue for the reduction, removal, and/or treatment of: warts, acne scars, nevi epidermal, syringoma. Vaporization/coagulation of warts. Pixel: The Alma Hybrid Pixel CO2 fractional applicator, with wavelength of 10600 nm is indicated for: The ablation, vaporization, and coagulation of soft tissue in dermatology and plastic surgery in the performance of skin resurfacing. ProScan: The Alma Hybrid ProScan CO2 fractional applicator, with wavelength of 10600 nm is indicated for: • Laser skin resurfacing (ablation and/or vaporization) of soft tissue. The Alma Hybrid ProScan 1570nm fractional applicator, with wavelength of 1570 nm, is indicated for: • Use in dermatological procedures requiring fractional skin resurfacing and coagulation of soft tissue. The Alma Hybrid ProScan CO2 & 1570nm fractional applicator, with wavelengths of 10600 nm & 1570nm is indicated for laser skin resurfacing (ablation and/or vaporization) of soft tissue.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K251230 (Alma Lasers, Inc., 2025)
The Alma Hybrid Laser System (Pixel and HyLight CO2 Applicators) is intended for use in surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including aesthetic surgery (dermatology and plastic surgery), podiatry, gynecology, neurosurgery, orthopedics (soft tissue), arthroscopy (knee). The Alma Hybrid Laser System is cleared for use for the particular indications as follows: Dermatology & Plastic Surgery The ablation, vaporization, excision, incision, and coagulation of soft tissue in dermatology and plastic surgery in the performance of: of soft tissue in dermatology and plastic surgery in the performance of: • Laser skin resurfacing • Laser dermabrasion • Laser burn debridement. Laser skin resurfacing (ablation and/or vaporization) for the treatment of: • Wrinkles, rhytids, and furrows (including fines lines and texture irregularities) Clinical literature demonstrates that skin resurfacing of wrinkles, rhytids, and furrows with CO2 laser increases the amount of sub-epidermal collagen.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: September 4, 2026 · How we verify
Axis runs $0–$160k. Reference figures, not current offers. Used asking prices are not completed-sale values.
Not verified
We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.
Price sourcesSources, dates and configurations
Key factsCompany, specifications and verification dates
| Manufacturer | Alma |
|---|---|
| Company | Owner: Sisram Medical Ltd (HKEx: 1696), controlled by Shanghai Fosun Pharmaceutical (subsidiary, since 2013) · Distribution: direct |
| Parent company | Alma (Sisram Medical) |
| Brand owner | Alma |
| Built by (OEM) | Alma Lasers Ltd. |
| Category | CO2 Fractional/Ablative |
| Technology | CO2 10600nm + 1570nm fiber hybrid |
| FDA status | FDA Cleared |
| 510(k) citation | K203441, K251230 |
| New price range | $120k–$160k |
| Used asking range | $70k–$100k |
| Consumables | Not published |
| Launch year | 2021 |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
Simultaneous ablative/non-ablative HyGrid handpiece
How it worksTechnology and manufacturing
How the technology works
Three energy sources: a 10,600nm CO2 (vaporizes tissue — the corrective heavy lifter), a 1570nm fiber laser (heats dermal columns without removing skin — the collagen stimulator with minimal downtime), and an ultrasound module (IMPACT) that pushes topicals into freshly-made channels.
The HyGrid handpiece interlaces CO2 and 1570nm micro-spots in a single grid — one pass delivers, say, 30% ablative and 70% non-ablative injury. Treats wrinkles, acne and surgical scars, sun damage and laxity with recovery tunable from a weekend to a week.
Conceptually HALO's hybrid logic with CO2 instead of erbium — deeper thermal effect, more downtime headroom at the top end.
Patented technology
HyGrid is the real proprietary piece — co-registered dual-wavelength delivery in one scan pattern rather than two sequential passes; IMPACT ultrasound-assisted delivery is carried over from Alma's surgical line.
Origin
Caesarea, Israel (Alma Lasers; parent Sisram Medical/Fosun Pharma).
FDA & regulatory detailClearance timeline, authorization route and citation notes
Launch 2021 · Clearance 2021 · K203441; K251230
510(k): K203441 and K251230. Checked 4 Sep 2026.
FDA-cleared indications (verbatim)
K203441 (Alma Lasers, Ltd., 2021)
The Alma Hybrid Laser System, Delivery Devices, Applicators and Accessories are intended for use in surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including: aesthetic surgery (dermatology and plastic surgery). HyLight-CO2: The Alma Hybrid CO2 non-fractional applicator, with wavelength of 10600 nm is cleared for use for the particular indications as follows: Dermatology & Plastic Surgery — The ablation, vaporization, excision, incision, and coagulation of soft tissue in dermatology and plastic surgery in the performance of: • laser skin resurfacing • laser derm-abrasion • laser burn debridement. Laser skin resurfacing (ablation and/or vaporization) of soft tissue for the reduction, removal, and/or treatment of: warts, acne scars, nevi epidermal, syringoma. Vaporization/coagulation of warts. Pixel: The Alma Hybrid Pixel CO2 fractional applicator, with wavelength of 10600 nm is indicated for: The ablation, vaporization, and coagulation of soft tissue in dermatology and plastic surgery in the performance of skin resurfacing. ProScan: The Alma Hybrid ProScan CO2 fractional applicator, with wavelength of 10600 nm is indicated for: • Laser skin resurfacing (ablation and/or vaporization) of soft tissue. The Alma Hybrid ProScan 1570nm fractional applicator, with wavelength of 1570 nm, is indicated for: • Use in dermatological procedures requiring fractional skin resurfacing and coagulation of soft tissue. The Alma Hybrid ProScan CO2 & 1570nm fractional applicator, with wavelengths of 10600 nm & 1570nm is indicated for laser skin resurfacing (ablation and/or vaporization) of soft tissue.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K251230 (Alma Lasers, Inc., 2025)
The Alma Hybrid Laser System (Pixel and HyLight CO2 Applicators) is intended for use in surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including aesthetic surgery (dermatology and plastic surgery), podiatry, gynecology, neurosurgery, orthopedics (soft tissue), arthroscopy (knee). The Alma Hybrid Laser System is cleared for use for the particular indications as follows: Dermatology & Plastic Surgery The ablation, vaporization, excision, incision, and coagulation of soft tissue in dermatology and plastic surgery in the performance of: of soft tissue in dermatology and plastic surgery in the performance of: • Laser skin resurfacing • Laser dermabrasion • Laser burn debridement. Laser skin resurfacing (ablation and/or vaporization) for the treatment of: • Wrinkles, rhytids, and furrows (including fines lines and texture irregularities) Clinical literature demonstrates that skin resurfacing of wrinkles, rhytids, and furrows with CO2 laser increases the amount of sub-epidermal collagen.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
CO2 fractional — CO2 10600nm + 1570nm fiber hybrid
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: Alma (Sisram Medical)
Legal manufacturer: Alma Lasers Ltd. (Israel)
Applicant on the FDA record
Alma Lasers Ltd.The applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
Supplies & recurring costs
Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
Annual service & support
No annual service cost documented yet.
Payback calculatorModel your own volume, labor and service costs
Estimate your payback
Pre-filled from our published Alma Hybrid data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.
Start from
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
Pre-filled from the midpoint of the published new-price range
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.
Annual service contract ÷ 12, if you carry one.
Your estimate
Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
ComplianceScreening and contraindications on the manufacturer's record
Contraindications & screening
Standard ablative screening — recent isotretinoin, active infection/herpes, keloids, pregnancy; darker Fitzpatrick types need conservative CO2 fractions and pigment priming.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
History6 tracked changes
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
September 4, 2026
FDA status
Unknown → Cleared
Clearance located on openFDA
Source: Council round 2 audit, verified on openFDA 2026-09-04
September 4, 2026
FDA status
Unknown → Cleared
Source: Catalog update
September 4, 2026
510(k) numbers
K-number set re-verified against openFDA
Source: Council round 2 audit, verified on openFDA 2026-09-04
September 4, 2026
FDA K-numbers
Source: Catalog update
September 4, 2026
FDA source URL
Source: Catalog update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "Alma Hybrid — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.